...
ikna-img

Ikena Oncology Inc, Common Stock

IKNA

NMQ

$1.7

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$82.04M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
61.26K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.48
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.22 L
$2.32 H
$1.7

About Ikena Oncology Inc, Common Stock

Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the United States. Its lead program is IK-930, an internally discovered, oral, TEAD1-selective, small molecule inhibitor of the Hippo pathway. The company also develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIKNASectorS&P500
1-Week Return--1.8%-0.77%
1-Month Return-2.86%-3.48%0.71%
3-Month Return-0.58%-7.2%8.81%
6-Month Return-6.08%-1.54%12.32%
1-Year Return-10.99%8.39%30.57%
3-Year Return-88.04%6.07%29.21%
5-Year Return-94.69%44.07%91.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue13.75M9.19M30.98M15.62M9.16M[{"date":"2019-12-31","value":44.39,"profit":true},{"date":"2020-12-31","value":29.67,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.41,"profit":true},{"date":"2023-12-31","value":29.56,"profit":true}]
Cost of Revenue24.94M44.85M47.11M2.03M1.02M[{"date":"2019-12-31","value":52.94,"profit":true},{"date":"2020-12-31","value":95.2,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":4.32,"profit":true},{"date":"2023-12-31","value":2.17,"profit":true}]
Gross Profit(11.19M)(35.65M)(16.12M)13.58M8.14M[{"date":"2019-12-31","value":-82.34,"profit":false},{"date":"2020-12-31","value":-262.46,"profit":false},{"date":"2021-12-31","value":-118.69,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.92,"profit":true}]
Gross Margin(81.33%)(387.79%)(52.03%)86.98%88.86%[{"date":"2019-12-31","value":-91.52,"profit":false},{"date":"2020-12-31","value":-436.38,"profit":false},{"date":"2021-12-31","value":-58.56,"profit":false},{"date":"2022-12-31","value":97.88,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses32.24M53.71M65.12M86.52M84.58M[{"date":"2019-12-31","value":37.27,"profit":true},{"date":"2020-12-31","value":62.08,"profit":true},{"date":"2021-12-31","value":75.27,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.75,"profit":true}]
Operating Income(18.49M)(44.52M)(34.14M)(70.90M)(75.42M)[{"date":"2019-12-31","value":-1849200000,"profit":false},{"date":"2020-12-31","value":-4451900000,"profit":false},{"date":"2021-12-31","value":-3413800000,"profit":false},{"date":"2022-12-31","value":-7090400000,"profit":false},{"date":"2023-12-31","value":-7541700000,"profit":false}]
Total Non-Operating Income/Expense--46.00K4.29M-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":1.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(16.82M)(44.26M)(34.12M)(68.77M)(68.33M)[{"date":"2019-12-31","value":-1681700000,"profit":false},{"date":"2020-12-31","value":-4425600000,"profit":false},{"date":"2021-12-31","value":-3411500000,"profit":false},{"date":"2022-12-31","value":-6876500000,"profit":false},{"date":"2023-12-31","value":-6832800000,"profit":false}]
Income Taxes(1.68M)93.70K307.44K(2.14M)(162.00K)[{"date":"2019-12-31","value":-544.82,"profit":false},{"date":"2020-12-31","value":30.48,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-695.74,"profit":false},{"date":"2023-12-31","value":-52.69,"profit":false}]
Income After Taxes--(34.42M)(66.63M)-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-3442244200,"profit":false},{"date":"2022-12-31","value":-6662600000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(16.82M)(44.26M)(34.12M)(68.75M)(62.77M)[{"date":"2019-12-31","value":-1681700000,"profit":false},{"date":"2020-12-31","value":-4425600000,"profit":false},{"date":"2021-12-31","value":-3411500000,"profit":false},{"date":"2022-12-31","value":-6875500000,"profit":false},{"date":"2023-12-31","value":-6277400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(16.82M)(44.26M)(34.12M)(66.63M)(68.17M)[{"date":"2019-12-31","value":-1681700000,"profit":false},{"date":"2020-12-31","value":-4425600000,"profit":false},{"date":"2021-12-31","value":-3411500000,"profit":false},{"date":"2022-12-31","value":-6662600000,"profit":false},{"date":"2023-12-31","value":-6816600000,"profit":false}]
EPS (Diluted)-(1.60)(3.20)(1.92)(1.70)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-159.83,"profit":false},{"date":"2021-12-31","value":-320,"profit":false},{"date":"2022-12-31","value":-192,"profit":false},{"date":"2023-12-31","value":-170,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IKNA
Cash Ratio 14.94
Current Ratio 15.32

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IKNA
ROA (LTM) -22.06%
ROE (LTM) -37.09%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IKNA
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IKNA
Trailing PE NM
Forward PE NM
P/S (TTM) 124.49
P/B 0.61
Price/FCF NM
EV/R 0.93
EV/Ebitda NM

FAQs

What is Ikena Oncology Inc share price today?

Ikena Oncology Inc (IKNA) share price today is $1.7

Can Indians buy Ikena Oncology Inc shares?

Yes, Indians can buy shares of Ikena Oncology Inc (IKNA) on Vested. To buy Ikena Oncology Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IKNA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ikena Oncology Inc be purchased?

Yes, you can purchase fractional shares of Ikena Oncology Inc (IKNA) via the Vested app. You can start investing in Ikena Oncology Inc (IKNA) with a minimum investment of $1.

How to invest in Ikena Oncology Inc shares from India?

You can invest in shares of Ikena Oncology Inc (IKNA) via Vested in three simple steps:

  • Click on Sign Up or Invest in IKNA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Ikena Oncology Inc shares
What is Ikena Oncology Inc 52-week high and low stock price?

The 52-week high price of Ikena Oncology Inc (IKNA) is $2.32. The 52-week low price of Ikena Oncology Inc (IKNA) is $1.22.

What is Ikena Oncology Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ikena Oncology Inc (IKNA) is

What is Ikena Oncology Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ikena Oncology Inc (IKNA) is 0.61

What is Ikena Oncology Inc dividend yield?

The dividend yield of Ikena Oncology Inc (IKNA) is 0.00%

What is the Market Cap of Ikena Oncology Inc?

The market capitalization of Ikena Oncology Inc (IKNA) is $82.04M

What is Ikena Oncology Inc’s stock symbol?

The stock symbol (or ticker) of Ikena Oncology Inc is IKNA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top